selected scholarly activity
-
conferences
- Multi-center clinical evaluation of a precision-controlled rubidium-82 elution system for PET myocardial perfusion imaging. European Heart Journal. 975-976. 2018
- An Approach to New Oncologic PET Agent Development. Journal of Nuclear Medicine. 2017
- Multi-center performance evaluation of a prototype rubidium-82 elution system for low-dose PET myocardial perfusion imaging. Journal of Nuclear Medicine. 2016
- Initial Evaluation of [18F]GE-180 PET Imaging in Relapsing-Remitting Multiple Sclerosis Patients. European Journal of Nuclear Medicine and Molecular Imaging. S276-S277. 2015
- Evaluation of [F-18]GE-180 PET imaging in relapsing-remitting multiple sclerosis patients: a first-in-human study. Multiple Sclerosis. 195-196. 2015
- The role of PET-CT in treatment decision making for women with locally advanced cervical cancer.. Journal of Clinical Oncology. 5523-5523. 2015
- The feasibility, acceptability and safety of Molecular Breast Imaging (MBI) using a breast specific gamma camera and 99mTc-sestamibi in patients with a high risk of breast cancer. European Journal of Nuclear Medicine and Molecular Imaging. S462-S462. 2013
- Positron emission tomography/computed tomography (PET/CT) for the diagnosis of recurrent cancer (PETREC): A multicenter, prospective cohort study.. Journal of Clinical Oncology. 2012
- Low-dose 3D PET rubidium ARMI (Alternative Radiopharmaceutical for Myocardial Imaging) multicentre trial standards and quality assurance. Journal of Nuclear Medicine. 2012
- Survival analysis of PETCAM: A multicenter randomized controlled trial of PET/CT versus no PET/CT for patients with resectable liver colorectal adenocarcinoma metastases.. Journal of Clinical Oncology. 390-390. 2012
- 516 Cardiac fdg pet results impact decisions and identify patients likely to benefit from revascularization in a multi-center provincial registry (CADRE). Canadian Journal of Cardiology. S249-S250. 2011
- 578 Pet imaging standards and quality assurance for the rubidium ARMI (alternative radiopharmaceutical for myocardial imaging) multicentre trial. Canadian Journal of Cardiology. S270-S270. 2011
- AN ONTARIO CLINICAL ONCOLOGY GROUP (OCOG) RANDOMIZED TRIAL (PET START) OF FDG PET/CT IN PATIENTS WITH STAGE 3 NON-SMALL CELL LUNG CANCER (NSCLC): IMPACT OF PET ON RADIATION TREATMENT VOLUMES. Journal of Thoracic Oncology. S428-S428. 2011
- An Ontario Clinical Oncology Group (OCOG) randomized controlled trial (RCT) assessing FDG PET/CT in resectable liver colorectal adenocarcinoma metastases (CAM). Journal of Clinical Oncology. 2011
- An Ontario Clinical Oncology Group (OCOG) randomized trial (PET START) of FDG PET/CT in patients with stage III non-small cell lung cancer (NSCLC): Predictors of overall survival.. Journal of Clinical Oncology. 2011
- DOES FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY GUIDED MANAGEMENT IMPROVE QUALITY OF LIFE IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION? A QUALITY OF LIFE SUBSTUDY OF THE PARR2 TRIAL. Journal of the American College of Cardiology. E799-E799. 2011
- A prospective study to evaluate the role of 2-[18f] fluoro-2-deoxy-d-glucose (FDG)-positron emission tomography (PET), breast magnetic resonance imaging (MRI), and breast ultrasonography in monitoring tumor responses in patients with locally advanced breast cancer (LABC) undergoing neoadjuvant chemotherapy.. Journal of Clinical Oncology. 595-595. 2010
- Survival of non-small cell lung cancer (NSCLC) patients in a randomized trial as predicted by the FDG-PET standardized uptake value (SUV).. Journal of Clinical Oncology. 7076-7076. 2010
- Superior value of [18F]6-FDOPA PET/CT in staging of neuroendocrine tumors. Journal of Nuclear Medicine. 2010
- PET-CT compared to invasive mediastinal staging in non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 2009
-
Reactivity and Selectivity of F2 Toward 3,4,6-Tri-O-acetyl-
D -Glucal in Anhydrous HF: Synthesis of [18F]2-Fluoro-2-deoxy-β-D -allose and Its Use for the Detection of a Breast Tumor. ACS Symposium Series. 211-235. 2009 - A prospective study evaluating 18F-Fluorodeoxyglucose (18FDG) positron emission tomography (PET) in the assessment of axillary nodal spread in women undergoing sentinel lymph node biopsy (SLNB) for breast cancer. Journal of Clinical Oncology. 533-533. 2008
- A randomized controlled trial (RCT) of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) versus conventional imaging (CI) in staging potentially resectable non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 7502-7502. 2008
- Identification of high risk patients with ischemic cardiomyopathy using FDG PET. Circulation. 717-718. 2007
- Hibernating myocardium identifies high risk patients with ischemic cardiomyopathy. (Substudy of the PARR-2 trial). Canadian Journal of Cardiology. 229C-229C. 2007
- FDG PET-guided therapy versus standard care severe LV dysfunction (The PARR-2 trial). Journal of the American College of Cardiology. 100A-101A. 2007
- Application of fluorine-18 in the syntheses of PET radiotracers. 26th Annual Canadian Nuclear Society Conference and 29th CNS/CNA Student Conference. 687. 2005
- FLUORINE-18 LABELLED AROMATIC AMINO ACIDS FOR TUMOR IMAGING USING PET. Journal of Labelled Compounds and Radiopharmaceuticals. S216-S216. 2005
- REGIO- AND STEREOSELECTIVE ELECTROPHILIC FLUORINATION OF 3,4,6-TRI-O-ACETYL-D-GLUCAL (TAG) IN ACIDIC MEDIUM. Journal of Labelled Compounds and Radiopharmaceuticals. S202-S202. 2005
- Positron emission tomography what's all the hype?. Annual Canadian Nuclear Society Conference. 873-898. 2004
- CARDIAC RISK STRATIFICATION PRIOR TO VASCULAR-SURGERY. Journal of Nuclear Medicine. P74-P75. 1993
- Cardiac risk stratification using dipyridamole myocardial perfusion imaging and ambulatory ECG monitoring prior to vascular surgery. European Journal of Vascular and Endovascular Surgery. 151-155. 1993
- ANTIMYOSIN IMAGING IN UNSTABLE ANGINA. Circulation. 797-797. 1992
- PREDICTION OF POSTINFARCTION ISCHEMIA WITH COMBINED ANTIMYOSIN AND THALLIUM IMAGING. Circulation. 202-202. 1990
- Comparison of left ventricular function and myocardial perfusion for evaluating perioperative cardiac risk of abdominal aortic surgery.. Canadian Journal of Surgery. 224-228. 1990
- COMPARISON OF DIPYRIDAMOLE THALLIUM IMAGING AND CLINICAL INDEXES FOR THE PREDICTION OF CARDIAC RISK FOLLOWING VASCULAR-SURGERY. British Journal of Surgery. A349-A350. 1990
- EVALUATION OF CEREBRAL PERFUSION IMAGING WITH TECHNETIUM-99M HM-PAO FOLLOWING CEREBRAL TRAUMA IN PATIENTS WITH ACUTE AND CHRONIC SYMPTOMATOLOGY. Journal of Nuclear Medicine. 2028-2028. 1988
- CLINICAL USE OF TC-99M HMPAO FOLLOWING ACUTE AND NON-ACUTE CEREBRAL TRAUMA. European Journal of Nuclear Medicine and Molecular Imaging. 311-311. 1988
- A PRELIMINARY-STUDY OF THE CLINICAL UTILITY OF TC-99M LABELED WHITE BLOOD-CELLS (WBC). Clinical and Investigative Medicine. B7-B7. 1988
- CLINICAL USE OF CEREBRAL PERFUSION IMAGING WITH TC-99M HMPAO IN PEDIATRIC-PATIENTS. Child's Nervous System. 187-187. 1988
- EVALUATION OF TECHNETIUM-99M DITHIOCARBAMATES AS POTENTIAL RADIOPHARMACEUTICALS FOR BRAIN IMAGING WITH SPECT. Clinical and Investigative Medicine. B7-B7. 1988
- INITIAL CLINICAL-EXPERIENCE WITH TC-99M HMPAO IN 85 PATIENTS. Clinical and Investigative Medicine. B3-B3. 1988
- USE OF TC-99M HMPAO IN CEREBRAL TRAUMA. Clinical and Investigative Medicine. B12-B12. 1988
- CLINICAL UTILITY OF CEREBRAL PERFUSION IMAGING WITH TC-99M HMPAO IN ADULT AND PEDIATRIC PRACTICE. Australian and New Zealand Journal of Medicine. 487-487. 1988
- CLINICAL USE OF HMPAO IN ADULTS AND PEDIATRIC-PATIENTS. Journal of Nuclear Medicine. 1793-1794. 1987
- DOMPERIDONE (MOTILIUM) IMPROVES SYMPTOMS AND SOLID-PHASE GASTRIC-EMPTYING IN DIABETIC GASTROPARESIS (DGP). American Journal of Gastroenterology. 975-975. 1987
- TC-99M DITHIOCARBAMATES AS POTENTIAL AGENTS FOR BRAIN IMAGING. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. 120-NUCL. 1987
- DOMPERIDONE IMPROVES SYMPTOMS AND SOLID-PHASE GASTRIC-EMPTYING IN DIABETIC GASTROPARESIS (DGP). Clinical and Investigative Medicine. B69-B69. 1987
- PAIRED COMPARISON OF TC-99M SULFUR COLLOID (TC-SC) INVIVO LABELED CHICKEN LIVER (TC-SC LIVER) TO TC-SC SCRAMBLED EGG (TC-SC EGG) IN GASTRIC-EMPTYING STUDIES. Digestive Diseases and Sciences. S447-S447. 1986
- CISAPRIDE IS EFFECTIVE IN LONG-TERM TREATMENT OF DIABETIC GASTROPARESIS (DGP). American Journal of Gastroenterology. 855-855. 1986
- PAIRED COMPARISON OF TC-99M SULFUR COLLOID (TC-SC) INVIVO LABELED CHICKEN LIVER (TC-SC LIVER) TO TC-SC SCRAMBLED EGG (TC-SC EGG) IN GASTRIC-EMPTYING STUDIES. Gastroenterology. 1369-1369. 1986
- IS TC-99M SULFUR COLLOID INVIVO LABELED CHICKEN LIVER A GOOD GOLD STANDARD FOR GASTRIC-EMPTYING STUDIES. Clinical and Investigative Medicine. A159-A159. 1985
- I-123 FOR THYROID STUDIES IN CHILDREN. International Journal of Nuclear Medicine and Biology. 233-234. 1982
- PEDIATRIC ARTHRIDITES AND USELESS JOINT SCANS. Journal of Nuclear Medicine. P7-P7. 1982
- Radionuclide angiography and endomyocardial biopsy in the assessment of doxorubicin cardiotoxicity. American Journal of Cardiology. 401-401. 1981
- ADRIAMYCIN CARDIOTOXICITY - CORRELATION OF RADIONUCLIDE ANGIOGRAPHY AND PATHOLOGY. Australian and New Zealand Journal of Medicine. 580-580. 1981
- GATED RADIONUCLIDE ANGIOGRAPHY (GNA) AND ENDOMYOCARDIAL BIOPSY (EMB) IN THE ASSESSMENT OF DOXORUPICIN CARDIOTOXICITY (DCT). Proceedings / Annual Meeting of the American Association for Cancer Research [and] Annual Meeting of the American Society of Clinical Oncology. American Association for Cancer Research. Meeting. 334-334. 1981
- ADRIAMYCIN CARDIOTOXICITY - CORRELATION OF RADIONUCLIDE ANGIOGRAPHY AND PATHOLOGY. Journal of Nuclear Medicine. P74-P74. 1980
-
journal articles
- Effect of Positron Emission Tomography Imaging in Women With Locally Advanced Cervical Cancer. JAMA network open. 1:e182081-e182081. 2018
- Characterization of 3-Dimensional PET Systems for Accurate Quantification of Myocardial Blood Flow. Journal of Nuclear Medicine. 58:103-109. 2017
- Long-Term Follow-Up of Outcomes With F-18-Fluorodeoxyglucose Positron Emission Tomography Imaging–Assisted Management of Patients With Severe Left Ventricular Dysfunction Secondary to Coronary Disease. Circulation. Cardiovascular Imaging. 9:e004331. 2016
- Positron Emission Tomography–Computed Tomography (PET-CT) Versus No PET-CT in the Management of Potentially Resectable Colorectal Cancer Liver Metastases: Cost Implications of a Randomized Controlled Trial. JCO Oncology Practice. 12:e765-e774. 2016
- Effectiveness of Quality Improvement Interventions at Reducing Inappropriate Cardiac Imaging. Circulation. Cardiovascular Quality and Outcomes. 9:7-13. 2016
- Imaging Biomarkers in Immunotherapy. Biomarkers in Cancer. 8s2:BIC.S31805-BIC.S31805. 2016
- Biological Response of Positron Emission Tomography Scan Exposure and Adaptive Response in Humans. Dose-Response. 13:155932581561190-155932581561190. 2015
- 18F-fluorodeoxyglucose positron-emission tomography-computed tomography to diagnose recurrent cancer. British Journal of Cancer. 112:1737-1743. 2015
- PET Screening for Metastatic Colorectal Adenocarcinoma—Reply. Journal of the American Medical Association (JAMA). 312:1256-1256. 2014
- Effect of PET Before Liver Resection on Surgical Management for Colorectal Adenocarcinoma Metastases. Journal of the American Medical Association (JAMA). 311:1863-1863. 2014
- Clinical Interpretation Standards and Quality Assurance for the Multicenter PET/CT Trial Rubidium-ARMI. Journal of Nuclear Medicine. 55:58-64. 2014
- Clinical Utility of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Staging of Patients with Potentially Resectable Esophageal Cancer. Journal of Thoracic Oncology. 8:1563-1569. 2013
- Vertebral fracture prevalence in a referral population of 750 Canadian men and women. Clinical Radiology. 67:1061-1068. 2012
- Radionuclide Therapy in Neuroendocrine Tumours: A Systematic Review. Clinical Oncology. 24:294-308. 2012
- Prospective Study of 2-[18F]Fluorodeoxyglucose Positron Emission Tomography in the Assessment of Regional Nodal Spread of Disease in Patients With Breast Cancer: An Ontario Clinical Oncology Group Study. Journal of Clinical Oncology. 30:1274-1279. 2012
- PET/CT using 18F-FDOPA provides improved staging of carcinoid tumor patients in a Canadian setting. Nuclear Medicine Communications. 33:322-330. 2012
- The Use of 18F-FDG PET in the Diagnosis of Cardiac Sarcoidosis: A Systematic Review and Metaanalysis Including the Ontario Experience. Journal of Nuclear Medicine. 53:241-248. 2012
- Does FDG PET-Assisted Management of Patients With Left Ventricular Dysfunction Improve Quality of Life? A Substudy of the PARR-2 Trial. Canadian Journal of Cardiology. 28:54-61. 2012
- Positron Emission Tomography-Computed Tomography Compared with Invasive Mediastinal Staging in Non-small Cell Lung Cancer: Results of Mediastinal Staging in the Early Lung Positron Emission Tomography Trial. Journal of Thoracic Oncology. 6:1367-1372. 2011
- Radiation doses originating from diagnostic procedures during the treatment and follow-up of children and adolescents with malignant lymphoma. Journal of Radiological Protection. 31:83-93. 2011
- Combined Vertebral Fracture Assessment and Bone Mineral Density Measurement: A Patient-friendly New Tool with an Important Impact on the Canadian Risk Fracture Classification. Canadian Association of Radiologists Journal. 61:194-200. 2010
- Is a Fixed Value for the Least Significant Change Appropriate?. Journal of Clinical Densitometry. 13:18-23. 2010
- Evidence-Based Approach to the Introduction of Positron Emission Tomography in Ontario, Canada. Journal of Clinical Oncology. 27:5607-5613. 2009
- Increasing Benefit From Revascularization Is Associated With Increasing Amounts of Myocardial Hibernation. JACC Cardiovascular Imaging. 2:1060-1068. 2009
- Positron Emission Tomography Plus Computed Tomography for Staging Early Lung Cancer. ACP journal club. 151:I-I. 2009
- Is Thyroid Screening Necessary for Nuclear Medicine Personnel Receiving and Administering Capsules Containing Large Doses of 131I?. Journal of Medical Imaging and Radiation Sciences. 40:60-63. 2009
- 6-l-18F-Fluorodihydroxyphenylalanine PET in Neuroendocrine Tumors: Basic Aspects and Emerging Clinical Applications. Journal of Nuclear Medicine. 49:573-586. 2008
- Is There a Role for Positron Emission Tomography in Breast Cancer Staging?. Journal of Clinical Oncology. 26:712-720. 2008
- 18Fluorodeoxyglucose Positron Emission Tomography in the Diagnosis and Staging of Lung Cancer: A Systematic Review. Journal of the National Cancer Institute. 99:1753-1767. 2007
- F-18-Fluorodeoxyglucose Positron Emission Tomography Imaging-Assisted Management of Patients With Severe Left Ventricular Dysfunction and Suspected Coronary Disease. Journal of the American College of Cardiology. 50:2002-2012. 2007
- CCS/CAR/CANM/CNCS/CanSCMR joint position statement on advanced noninvasive cardiac imaging using positron emission tomography, magnetic resonance imaging and multidetector computed tomographic angiography in the diagnosis and evaluation of ischemic heart disease – executive summary. Canadian Journal of Cardiology. 23:107-119. 2007
- Radiation exposure for ‘caregivers’ during high-dose outpatient radioiodine therapy. Radiation Protection Dosimetry. 123:62-67. 2007
- Treating the right patient at the right time: Access to cardiovascular nuclear imaging. Canadian Journal of Cardiology. 22:827-833. 2006
- Syntheses of [18F]5-fluoro-3-nitro-l-tyrosine. Journal of Fluorine Chemistry. 121:9-14. 2003
- Influence of bone densitometry results on the treatment of osteoporosis.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 164:777-781. 2001
- “Double Chamber” Right Ventricle Due to Prominent Trabeculation. Clinical Nuclear Medicine. 20:830-831. 1995
- Vascular Scalp Lesion’ From Cardiac Activity. Clinical Nuclear Medicine. 19:744-745. 1994
- Improved method to label beta-2 agonists in metered-dose inhalers with technetium-99m. Journal of Aerosol Science. 24:787-794. 1993
- Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer. International Journal of Radiation Oncology Biology Physics. 25:805-813. 1993
- Alternative formulations of technetium-99m HMPAO. Applied Radiation and Isotopes. 42:315-316. 1991
- Cerebral Perfusion Imaging with Technetium-99m HMPAO Following Cerebral Trauma. Clinical Nuclear Medicine. 15:383-388. 1990
- A kit for labelling erythrocytes or leukocytes with technetium-99m. Nuclear Medicine and Biology. 17:515-517. 1990
- Effect of granulocyte concentration on leukocyte labelling efficiency with 99mTc-HMPAO. Nuclear Medicine and Biology. 17:443-443. 1990
- In vitro comparison of HMPAO and gentisic acid for labelling leukocytes with 99mTc.. European Journal of Nuclear Medicine and Molecular Imaging. 16:299-302. 1990
- In vitro comparison of HMPAO and gentisic acid for labelling leukocytes with99mTc. European Journal of Nuclear Medicine and Molecular Imaging. 16:299-302. 1990
- Radiopharmaceutical factors in the variable quality of [99mTc]HM-PAO images of the brain.. Journal of Nuclear Medicine. 31:118-122. 1990
- Clinical use of technetium-99m HM-PAO for determination of brain death.. Journal of Nuclear Medicine. 30:1621-1626. 1989
- Routine determination of radiochemical purity of 99mTc-MIBI. Applied Radiation and Isotopes. 40:95-97. 1989
- Technetium-99m dithiocarbamates as potential brain agents: Evaluation of aliphatic and amine-containing analogues. Nuclear Medicine and Biology. 16:721-725. 1989
- Technetium-99m spiperone dithiocarbamate: A potential radiopharmaceutical for dopamine receptor imaging with SPECT. Applied Radiation and Isotopes. 40:547-549. 1989
- Technetium-99m HM-PAO stereoisomers: differences in interaction with glutathione.. Journal of Nuclear Medicine. 29:1998-2000. 1988
- Radiochemical purity of [99mTc]HM-PAO.. Journal of Nuclear Medicine. 29:572-573. 1988
- Technetium-99m Red Blood Cell Labeling in Patients Treated with Doxorubicin. Clinical Nuclear Medicine. 13:169-170. 1988
- Stabilization of stannous pyrophosphate kits with gentisic acid. Nuclear Medicine and Biology. 15:391-393. 1988
- Cerebral perfusion imaging.. Journal of Nuclear Medicine. 28:1364-1365. 1987
- TC-99M DIETHYLDITHIOCARBAMATE (DDC) - COMPARISON WITH TL-201 DDC AS AN AGENT FOR BRAIN IMAGING. Applied Radiation and Isotopes. 38:665-668. 1987
- Technetium-99m MDP Scintigraphy. Clinical Nuclear Medicine. 12:45-46. 1987
- Technetium-99m MDP scintigraphy. An insensitive tool for the detection of bone marrow metastases.. Clinical Nuclear Medicine. 12:45-46. 1987
- Technetium-99m diethyldithiocarbamate (DDC): Comparison with thallium-201 DDC as an agent for brain imaging. Applied Radiation and Isotopes. 38:665-668. 1987
- Splenic hemangioma presenting as a "hot spot" on radiocolloid scintigraphy.. Journal of Nuclear Medicine. 27:804-806. 1986
- Penile xenon washout studies. Urology. 23:624-624. 1984
- Radionuclide angiography and endomyocardial biopsy in the assessment of doxorubicin cardiotoxicity. Cancer. 53:1667-1674. 1984
- 123I for thyroid studies in children. International Journal of Nuclear Medicine and Biology. 9:232-233. 1982
- Iodine-123 for pediatric thyroid studies: An evaluation of its role. Journal of Radioanalytical and Nuclear Chemistry. 65:251-257. 1981